Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Short-term Investments history
Currency unavailable · from the balance sheet
No Short-term Investments data reported for this period type.
Short-term Investments vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $398.73M USD | +75.1% | — | 80.1% |
| Mar 2026 | $254.41M USD | +504.2% | — | 60.7% | |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $226.17M USD | +34.4% | +65.0% | 86.5% |
| Mar 2026 | $148.28M USD | -35.3% | -18.6% | 34.2% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $44.96M USD | — | — | 11.4% |
| Mar 2026 | $24.67M USD | -46.8% | — | 9.0% | |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $0 USD | -100.0% | — | 0.0% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -0.4% | +23.2% | 34.2% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.